Project partner spotlight: An interview with Daniel Lacerda de Oliveira from Farmanguinhos
Farmanguinhos, the federal governmental pharmaceutical laboratory of the Fiocruz Foundation in...
Read more
News
15 July 2020
Enhancing manufacturing capacity in endemic countries
As part of its activities to develop a pediatric formulation for the treatment of schistosomiasis in preschool-age children, the Pediatric Praziquantel...
Read more
News
15 July 2020
From the Chair: Partners in endemic countries play a vital role in tackling the treatment gap for preschool-age children suffering from schistosomiasis
Read more
News
19 June 2020
Publication: Schistosomiasis Control: Leave No Age Group Behind
The current treatment and monitoring strategies for schistosomiasis control programs mainly focus on school-aged children, with much less attention given to...
Read more
News
18 May 2020
Publication: Sensitive diagnostic tools and targeted drug administration strategies needed to eliminate schistosomiasis
While current treatment strategies have been instrumental in managing the disease burden of schistosomiasis, there are still many challenges remaining in...
Read more
News
24 April 2020
COVID-19 and the Pediatric Praziquantel Consortium
Over the last few weeks, thePediatric Praziquantel Consortium has been working hard to map the impacts of the COVID-19 crisis on the...
Read more
News
07 April 2020
The Pediatric Praziquantel Consortium marks World Health Day
Today is World Health Day – a global health awareness day celebrated each year on 7 April under the auspices of the World Health Organisation.
Last month, ahead of the COVID-19 crisis in Europe, the Pediatric Praziquantel Consortium Access team gathered in Utrecht for its annual face-to-face...
Read more
News
28 January 2020
The Pediatric Praziquantel Consortium supports first ever World Neglected Tropical Diseases Day
This Thursday, 30 January, marks the inaugural World Neglected Tropical Diseases (NTD) Day, an initiative created to draw attention to priority issues...
Read more
News
11 October 2019
Consortium intensifies its focus on future access
In September the Levo-Praziquantel 150mg Phase 3 trial was initiated in Kenya. With the project moving towards registration, the Consortium is intensifying...
Read more
News
18 September 2019
From the Program Lead: The Consortium has started the Phase III trial and is preparing for access
The pivotal phase III study with the L-praziquantel pediatric oral dispersible tablets (ODTs) has started, shortly after establishing the recommended dose...
Read more
News
18 September 2019
KEMRI “assante sana” for a wonderful meeting!
The Pediatric Praziquantel Consortium looks back on a very inspiring and successful Consortium meeting in Kisumu, the third largest city in Kenya located by...
